Compare Stocks

→ What is Medicare Supplement Insurance? (From Tranzact) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IKT Inhibikase Therapeutics	$1.73 -8.9%	$2.17	$0.79 ▼ $4.35	$11.22M	1.19	124,095 shs	5,095 shs
MBX Microbix Biosystems	C$0.33 -3.0%	C$0.38	C$0.23 ▼ C$0.47	C$44.38M	0.28	69,960 shs	7,350 shs
PDP Invesco Dorsey Wright Momentum ETF	$93.61 -0.2%	$95.49	$72.68 ▼ $99.60	$1.21B	1.02	25,961 shs	856 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IKT Inhibikase Therapeutics	-0.53%	-11.43%	-18.78%	-37.16%	-43.63%
MBX Microbix Biosystems	0.00%	-5.63%	-12.99%	-16.25%	-12.99%
PDP Invesco Dorsey Wright Momentum ETF	+0.06%	+1.91%	-4.59%	+7.89%	+27.55%

Thousands of investors use this no cost solution | Do you? (Ad)

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IKT Inhibikase Therapeutics	1.1126 of 5 stars	3.5	0.0	0.0	0.0	0.0	1.7	0.6
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IKT Inhibikase Therapeutics	3.00	Buy	$27.00	1,459.52% Upside
MBX Microbix Biosystems	3.00	Buy	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	0.00	N/A	$96.93	3.54% Upside

Current Analyst Ratings

Latest MBX, PDP, IKT, OBD, and DEST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/5/2024	IKT Inhibikase Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$27.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IKT Inhibikase Therapeutics	$260K	43.15	N/A	N/A	$1.78 per share	0.97
MBX Microbix Biosystems	C$22.42M	1.98	C$0.08 per share	4.13	C$0.20 per share	1.63
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IKT Inhibikase Therapeutics	-$19.03M	-$3.56	N/A	N/A	N/A	-5,886.15%	-107.54%	-91.82%	5/20/2024 (Estimated)
MBX Microbix Biosystems	C$3.72M	C$0.03	10.83	∞	N/A	16.57%	14.66%	1.87%	5/9/2024 (Estimated)
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	25.46	∞	N/A	N/A	N/A	N/A	N/A

Latest MBX, PDP, IKT, OBD, and DEST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/27/2024	Q4 2023	IKT Inhibikase Therapeutics	-$0.78	-$0.63	+$0.15	-$0.63	N/A	N/A
2/14/2024	Q1 2024	MBX Microbix Biosystems	N/A	C$0.02	+C$0.02	C$0.02	C$8.10 million	C$8.41 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IKT Inhibikase Therapeutics	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	$0.25	0.27%	N/A	N/A	N/A

Latest MBX, PDP, IKT, OBD, and DEST Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/15/2024	PDP Invesco Dorsey Wright Momentum ETF	Quarterly	$0.0275		3/18/2024	3/19/2024	3/22/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IKT Inhibikase Therapeutics	N/A	4.13	4.13
MBX Microbix Biosystems	24.53	8.53	5.57
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
IKT Inhibikase Therapeutics	3.81%
MBX Microbix Biosystems	0.42%
PDP Invesco Dorsey Wright Momentum ETF	N/A

Insider Ownership

Company	Insider Ownership
IKT Inhibikase Therapeutics	20.30%
MBX Microbix Biosystems	14.07%
PDP Invesco Dorsey Wright Momentum ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
IKT Inhibikase Therapeutics	8	6.48 million	5.16 million	Not Optionable
MBX Microbix Biosystems	N/A	136.55 million	N/A	Not Optionable
PDP Invesco Dorsey Wright Momentum ETF	N/A	12.89 million	N/A	Optionable

MBX, PDP, IKT, OBD, and DEST Headlines

Source	Headline
	Invesco Dorsey Wright Momentum ETF (PDP) finance.yahoo.com - November 28 at 1:49 PM
	Invesco DWA Developed Markets Momentum ETF (PIZ) investing.com - August 18 at 9:38 PM
	Invesco DWA Emerging Markets Momentum ETF thestreet.com - June 30 at 11:40 PM
	Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now? msn.com - February 24 at 7:31 AM
	GTO Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Total Return Bond ETF seekingalpha.com - February 23 at 9:30 PM
	Invesco DWA Consumer Cyclicals Momentum ETF (PEZ) finance.yahoo.com - December 25 at 7:09 PM
	PEZ Invesco Exchange-Traded Fund Trust - Invesco DWA Consumer Cyclicals Momentum ETF seekingalpha.com - October 11 at 5:36 PM
	Invesco DWA Momentum ETF declares quarterly distribution of $0.0830 seekingalpha.com - September 22 at 12:53 AM
	Invesco DWA Momentum ETF declares quarterly distribution of $0.0237 seekingalpha.com - June 21 at 4:46 PM
	Implied PDP Analyst Target Price: $93 nasdaq.com - June 21 at 11:44 AM
	Analysts Anticipate PDP Will Reach $91 nasdaq.com - April 18 at 10:11 AM
	PDP's Underlying Holdings Imply 12% Gain Potential nasdaq.com - April 7 at 6:44 PM
	Invesco DWA Consumer Staples Momentum ETF(PDP) fool.com - February 25 at 8:55 PM
	PDP's Underlying Holdings Could Mean 20% Gain Potential nasdaq.com - February 8 at 1:54 PM
	Gateway Advisory, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, Invesco DWA Momentum ETF, ... finance.yahoo.com - January 14 at 9:52 PM
	PDP Crowded With Sellers nasdaq.com - January 10 at 4:27 PM
	PDP Crosses Below Key Moving Average Level nasdaq.com - January 5 at 7:52 PM
	NewSquare Capital LLC Buys Invesco DWA Momentum ETF, FIRST TR ETF VI, SPDR Bloomberg High Yield ... gurufocus.com - November 8 at 2:57 PM
	Strid Group, LLC Buys First Trust DorseyWright DALI 1 ETF, Invesco DWA Momentum ETF, Hartford ... gurufocus.com - October 8 at 11:29 AM
	Here's Why Momentum ETFs Are Looking Good Buys nasdaq.com - August 10 at 7:04 PM
	Gateway Advisory, LLC Buys Invesco DWA Momentum ETF, IQ Real Return ETF, BTC iShares MSCI USA ... gurufocus.com - August 4 at 7:28 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Inhibikase Therapeutics

NYSE:IKT

Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, University of Bordeaux, and Michigan State University, as well as University of California; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Microbix Biosystems

TSE:MBX

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Invesco Dorsey Wright Momentum ETF

NASDAQ:PDP

PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial